Table 2.
Outcome events in inpatients with COVID-19 with or without pre-existing T2DM
| Total (N=1105) |
Non-T2DM (n=967) |
T2DM (n=138) |
P value | |
| Death, n (%) | 217 (19.6) | 168 (17.4) | 49 (35.5) | <0.001 |
| ARDS, n (%) | 379 (34.3) | 312 (32.3) | 67 (48.6) | <0.001 |
| Acute cardiac injury, n (%) | 198/1034 (19.1) | 151/904 (16.7) | 47/130 (36.2) | <0.001 |
| Acute liver injury, n (%) | 10/1042 (1.0) | 9/911 (1.0) | 1/131 (0.8) | >0.99 |
| Acute kidney injury, n (%) | 122/1073 (11.4) | 89/940 (9.5) | 33/133 (24.8) | <0.001 |
| Coagulopathy, n (%) | 133/1043 (12.8) | 101/914 (11.1) | 32/129 (24.8) | <0.001 |
| Hypoproteinemia, n (%) | 118/1079 (10.9) | 89/942 (9.4) | 29/137 (21.2) | <0.001 |
| Secondary infection, n (%) | 107/1016(10.5) | 89/889 (10.0) | 18/127 (14.2) | 0.153 |
The p value was calculated by χ2 test if not indicated. n indicates cases with available data.
ARDS, acute respiratory distress syndrome; T2DM, type 2 diabetes mellitus.